• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
187.17
  2.80  
+ 1.52%
693,773,000
213.33
127.69

Insider Trade Data

Date Insider Shares Type Value
03/16/2015 Bradbury, Daniel M 1,700 Sell $329,993
03/16/2015 Bradbury, Daniel M 1,700 Exchange $128,622
03/16/2015 Henry, Christian O 5,001 Sell $958,161
03/16/2015 Moeller, Gerald 2,700 Sell $522,073
03/16/2015 Moeller, Gerald 2,700 Exchange $204,282

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!